Post job

BioLargo CEO and executives

Executive Summary. Based on our data team's research, Dennis P. Calvert is the BioLargo's CEO. BioLargo has 27 employees, of which 21 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The BioLargo executive team is 29% female and 71% male.
  • 60% of the management team is White.
  • 8% of BioLargo management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at BioLargo?
Share your experience

Rate BioLargo's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Dennis P. Calvert

Chairman, President & Chief Executive Officer

Dennis P. Calvert's LinkedIn

I love my work as CEO of BioLargo, Inc. (OTCQB:BLGO) a sustainable technology company delivering products that make life better by solving the world’s most important problems that threaten water, food, agriculture, healthcare and energy. Our Clean Water technology is the Winner of Frost & Sullivan Water Industry Innovation Leader- and is the lowest cost and highest impact clean water technology known at 1/20th the cost and 100x more effective than the competition. Our odor elimination product (www.cupridyne.com) is a guaranteed winner and number one performer in the world. We have more! BioLargo's innovative technology is changing the world for good!

Kenneth Reay Code

Chief Science Officer

Kenneth Reay Code's LinkedIn

Kenneth R. Code holds the position of Chief Science Officer of BioLargo, Inc. and its wholly-owned subsidiary BioLargo Life Technologies, Inc. He is the Inventor of IOWC’s technology. He holds the following Patents and Publications CA 2191928 Absorbent Compositions, CA 2201825, CA 2278959, US 6146725, US 6328929, AU 9851139, India: 2247/CAL/97, PCT (International): WO 98/24486 His Accreditations include: Purchasing Management Association of Canada, Level IV, Council for the Accreditation of Pharmaceutical Reps, APMR, American Biological Safety Association, Advanced Disinfections, Canadian Blood Services, 75 Donations.

Joseph L. Provenzano

Board Member

Charles K. Dargan

Chief Financial Officer

Charles K. Dargan's LinkedIn

Charles 'Charley' Dargan is a Board Member at Anchor Audio; Chief Financial Officer at BIOLARGO, INC.; and CEO:Financial Entrepreneur Platform at Merriman Capital Inc and is based in Los Angeles, California. He has worked as Chief Financial Officer and Director at Semotus Solutions, Inc.; Chief Financial Officer at STWA; and Assistant Controller at Harman Marine. Charles works or has worked as Board Member at 411 Web Directory, Board Member at Singletree Resources Inc, and Managing Dir:Corp Finance at LH Friend Weinress Frankson. He attended DARTMOUTH COLLEGE between 1973 and 1977, USC Marshall School of Business between 1978 and 1980, and University of Southern California.

Dennis E. Marshall

Chairman of The Audit Committee

Kent C. Roberts III

Board Member

Jack B. Strommen

Board Member

John S. Runyan

Chairman of The Compensation Committee

Tonya Chandler

Board Member

A. J. Sexton

Board Member

Do you work at BioLargo?

Does leadership effectively guide BioLargo toward its goals?

BioLargo jobs

BioLargo board members

Name & TitleBio
Dennis P. Calvert

Chairman, President & Chief Executive Officer

Dennis P. Calvert's LinkedIn

I love my work as CEO of BioLargo, Inc. (OTCQB:BLGO) a sustainable technology company delivering products that make life better by solving the world’s most important problems that threaten water, food, agriculture, healthcare and energy. Our Clean Water technology is the Winner of Frost & Sullivan Water Industry Innovation Leader- and is the lowest cost and highest impact clean water technology known at 1/20th the cost and 100x more effective than the competition. Our odor elimination product (www.cupridyne.com) is a guaranteed winner and number one performer in the world. We have more! BioLargo's innovative technology is changing the world for good!

Kenneth Reay Code

Chief Science Officer

Kenneth Reay Code's LinkedIn

Kenneth R. Code holds the position of Chief Science Officer of BioLargo, Inc. and its wholly-owned subsidiary BioLargo Life Technologies, Inc. He is the Inventor of IOWC’s technology. He holds the following Patents and Publications CA 2191928 Absorbent Compositions, CA 2201825, CA 2278959, US 6146725, US 6328929, AU 9851139, India: 2247/CAL/97, PCT (International): WO 98/24486 His Accreditations include: Purchasing Management Association of Canada, Level IV, Council for the Accreditation of Pharmaceutical Reps, APMR, American Biological Safety Association, Advanced Disinfections, Canadian Blood Services, 75 Donations.

Joseph L. Provenzano

Board Member

Dennis E. Marshall

Chairman of The Audit Committee

Kent C. Roberts III

Board Member

Jack B. Strommen

Board Member

John S. Runyan

Chairman of The Compensation Committee

Tonya Chandler

Board Member

A. J. Sexton

Board Member

Shan Yong

Board Member

BioLargo executives FAQs

Zippia gives an in-depth look into the details of BioLargo, including salaries, political affiliations, employee data, and more, in order to inform job seekers about BioLargo. The employee data is based on information from people who have self-reported their past or current employments at BioLargo. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by BioLargo. The data presented on this page does not represent the view of BioLargo and its employees or that of Zippia.

BioLargo may also be known as or be related to BIOLARGO, BIOLARGO, INC., BioLargo and BioLargo, Inc.